194 related articles for article (PubMed ID: 9635721)
21. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
22. On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.
Stavrev P; Stavreva N; Ruggieri R; Nahum A
Phys Med Biol; 2015 Aug; 60(15):N293-9. PubMed ID: 26215150
[TBL] [Abstract][Full Text] [Related]
23. Substructure in the radiation survival response at low dose in cells of human tumor cell lines.
Skarsgard LD; Skwarchuk MW; Wouters BG; Durand RE
Radiat Res; 1996 Oct; 146(4):388-98. PubMed ID: 8927711
[TBL] [Abstract][Full Text] [Related]
24. Biological optimization of heterogeneous dose distributions in systemic radiotherapy.
Strigari L; D'Andrea M; Maini CL; Sciuto R; Benassi M
Med Phys; 2006 Jun; 33(6):1857-66. PubMed ID: 16872093
[TBL] [Abstract][Full Text] [Related]
25. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers.
Maciejewski B; Skladowski K; Zajusz A
Neoplasma; 1991; 38(5):513-22. PubMed ID: 1956467
[TBL] [Abstract][Full Text] [Related]
26. Analytic investigation into effect of population heterogeneity on parameter ratio estimates.
Schinkel C; Carlone M; Warkentin B; Fallone BG
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1323-30. PubMed ID: 17884301
[TBL] [Abstract][Full Text] [Related]
27. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
Zhang H; Zhong H; Barth RF; Cao M; Das IJ
Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
[TBL] [Abstract][Full Text] [Related]
28. The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?
Wang JZ; Li XA; Yu CX; DiBiase SJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1101-8. PubMed ID: 14575842
[TBL] [Abstract][Full Text] [Related]
29. The nucleo-shuttling of the ATM protein as a basis for a novel theory of radiation response: resolution of the linear-quadratic model.
Bodgi L; Foray N
Int J Radiat Biol; 2016; 92(3):117-31. PubMed ID: 26907628
[TBL] [Abstract][Full Text] [Related]
30. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
Scheidegger S; Lutters G; Bodis S
Z Med Phys; 2011 Sep; 21(3):164-73. PubMed ID: 21237624
[TBL] [Abstract][Full Text] [Related]
31. Equivalence of the linear-quadratic and two-lesion kinetic models.
Guerrero M; Stewart RD; Wang JZ; Li XA
Phys Med Biol; 2002 Sep; 47(17):3197-209. PubMed ID: 12361218
[TBL] [Abstract][Full Text] [Related]
32. Clinical radiobiology of glottic T1 squamous cell carcinoma.
Skladowski K; Tarnawski R; Maciejewski B; Wygoda A; Slosarek K
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):101-6. PubMed ID: 9989520
[TBL] [Abstract][Full Text] [Related]
33. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
34. Dose dependence of accelerated repopulation in head and neck cancer: Supporting evidence and clinical implications.
Shuryak I; Hall EJ; Brenner DJ
Radiother Oncol; 2018 Apr; 127(1):20-26. PubMed ID: 29534828
[TBL] [Abstract][Full Text] [Related]
35. Radiobiological assessment of non-standard and novel radiotherapy treatments using the linear-quadratic model.
Dale RG
Med Biol Eng Comput; 1993 Jan; 31(1):53-7. PubMed ID: 8326764
[TBL] [Abstract][Full Text] [Related]
36. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
[TBL] [Abstract][Full Text] [Related]
37. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
[TBL] [Abstract][Full Text] [Related]
38. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
39. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
[TBL] [Abstract][Full Text] [Related]
40. Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer.
Pedicini P; Strigari L; Benassi M
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e231-7. PubMed ID: 23332226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
